Education
About Us
Working with TipRanks
Follow Us
Provexis plc (GB:PXS)
:PXS
PXS Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.40p - 0.95p
Previous CloseN/A
Volume299.72K
Average Volume (3M)304.47K
Market Cap
£15.54M
Enterprise ValueN/A
Total Cash (Recent Filing)£478.20K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,345,891,400
10 Day Avg. Volume122,703
30 Day Avg. Volume304,467
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Provexis News
PXS FAQ
What was Provexis plc’s price range in the past 12 months?
Provexis plc lowest share price was 0.40p and its highest was 0.95p in the past 12 months.
What is Provexis plc’s market cap?
Provexis plc’s market cap is £15.54M.
When is Provexis plc’s upcoming earnings report date?
Provexis plc’s upcoming earnings report date is Dec 19, 2025 which is in 79 days.
How were Provexis plc’s earnings last quarter?
Currently, no data Available
Is Provexis plc overvalued?
According to Wall Street analysts Provexis plc’s price is currently Overvalued.
Does Provexis plc pay dividends?
Provexis plc does not currently pay dividends.
What is Provexis plc’s EPS estimate?
Provexis plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Provexis plc have?
Provexis plc has 2,345,891,400 shares outstanding.
What happened to Provexis plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Provexis plc?
Currently, no hedge funds are holding shares in GB:PXS
Company Description
Provexis plc
Provexis PLC is a biotechnology company based in the United Kingdom that focuses on the research, development, and commercialization of functional foods, medical foods, and dietary supplements. The company's flagship product is Fruitflow, a natural, scientifically-proven ingredient that promotes healthy blood flow and is used in a variety of food and dietary supplement products globally. Provexis operates primarily in the nutraceutical sector, aiming to provide innovative, science-backed solutions to enhance cardiovascular health.